Jennison Associates’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Jennison Associates’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,660,288	Closed	-$20.7M	–	850
2016 Q4	$20.7M	Buy	+1,660,288	New	+$20M	0.02%	406
2013 Q4	–	Sell	-891,161	Closed	-$16.4M	–	747
2013 Q3	$16.4M	Sell	891,161 -1,314,826	-60%	-$25.5M	0.02%	450
2013 Q2	$38.6M	Buy	+2,205,987	New	+$39.1M	0.04%	326

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Jennison Associates's ARIA Position: Q1 2017 in Review

Jennison Associates sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,660,288 shares — an estimated $20.7M sold.

Jennison Associates first reported a position in ARIA in Q2 2013 and held it in 3 quarters. The position peaked at $38.6M in Q2 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Jennison Associates reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Jennison Associates sold 1,660,288 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $20.7M.
Jennison Associates first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
Jennison Associates's Ariad Pharmaceuticals Inc position peaked at $38.6M in Q2 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.